Medicamen Biotech Ltd.
| BSE: 531146 | Sector: Health care |
| NSE: MEDICAMEQ | ISIN Code: INE646B01010 |
| BSE 00:00 | 08 Feb | 731.20 |
1.25 (0.17%) |
OPEN
721.55 |
HIGH
760.00 |
LOW
708.90 |
| NSE 00:00 | 08 Feb | 733.10 |
11.65 (1.61%) |
OPEN
717.05 |
HIGH
760.20 |
LOW
708.05 |
| OPEN | 721.55 |
| PREVIOUS CLOSE | 729.95 |
| VOLUME | 1310 |
| 52-Week high | 1219.00 |
| 52-Week low | 558.80 |
| P/E | 67.39 |
| Mkt Cap.(Rs cr) | 925 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Medicamen Biotech Ltd. (MEDICAMEQ) - Share Holding
| (in %) | Dec 2022 | Sep 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
| Promoter & Group | |||||
| Foreign | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Indian | 43.21 | 43.21 | 43.21 | 43.60 | 43.60 |
| Total Promoters | 43.21 | 43.21 | 43.21 | 43.60 | 43.60 |
| Non Promoter | |||||
| Institutions | 0.38 | 1.96 | 0.54 | 0.35 | 0.40 |
| Financial Institutions / Banks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Foreign Institutional Investors | 0.17 | 0.52 | 0.42 | 0.35 | 0.40 |
| Insurance Companies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mutual Funds / UTI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Institution | 56.42 | 54.84 | 56.25 | 56.06 | 56.01 |
| Indian Public | 31.36 | 30.94 | 35.26 | 35.02 | 34.31 |
| Others | 25.06 | 23.90 | 20.99 | 21.04 | 21.70 |
| Total Non Promoter | 56.80 | 56.80 | 56.79 | 56.41 | 56.41 |
| Total Promoter & Non Promoter | 100.01 | 100.01 | 100.00 | 100.01 | 100.01 |
| Custodians | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Grand Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Quick Links for Medicamen Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
